Back to Ken Fisher
Ken Fisher → LLY via Fisher Asset Management, LLC
Ken Fisher LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
16
Latest value
$6.1B
Q2 2026
Peak value
$6.1B
First seen
Q1 2023
Quarter-by-quarter history
Every disclosed snapshot
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $6.1B | 5.06M | — | — |
| Q1 2026 | $4.5B | 4.84M | — | — |
| Q4 2025 | $5B | 4.61M | — | — |
| Q3 2025 | $3.4B | 4.45M | — | — |
| Q2 2025 | $3.4B | 4.30M | — | — |
| Q1 2025 | $4.5B | 5.44M | — | — |
| Q4 2024 | $4B | 5.24M | — | — |
| Q3 2024 | $4.5B | 5.06M | — | — |
| Q2 2024 | $4.4B | 4.89M | — | — |
| Q1 2024 | $3.7B | 4.69M | — | — |
| Q4 2023 | $2.6B | 4.54M | — | — |
| Q4 2023 | $2.6B | 4.54M | — | — |
| Q3 2023 | $2.4B | 4.46M | — | — |
| Q2 2023 | $2B | 4.24M | — | — |
| Q2 2023 | $2B | 4.24M | — | — |
| Q1 2023 | $1.4B | 4.10M | — | — |